Diagnostyka S.A. (WSE:DIA)

Paramount Global Statistics

Total Valuation

Diagnostyka has a market cap or net worth of PLN 6.72 billion. The enterprise value is 7.63 billion.

Market Cap	6.72B
Enterprise Value	7.63B

Important Dates

The next estimated earnings date is Tuesday, August 26, 2025.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	Jun 3, 2025

Share Statistics

Diagnostyka has 33.76 million shares outstanding.

Current Share Class	33.76M
Shares Outstanding	33.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.41%
Float	n/a

Valuation Ratios

The trailing PE ratio is 28.96 and the forward PE ratio is 23.61. Diagnostyka's PEG ratio is 0.74.

PE Ratio	28.96
Forward PE	23.61
PS Ratio	3.26
PB Ratio	13.19
P/TBV Ratio	n/a
P/FCF Ratio	21.23
P/OCF Ratio	15.09
PEG Ratio	0.74

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.18, with an EV/FCF ratio of 24.13.

EV / Earnings	32.91
EV / Sales	3.70
EV / EBITDA	15.18
EV / EBIT	22.86
EV / FCF	24.13

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.83.

Current Ratio	0.84
Quick Ratio	0.70
Debt / Equity	1.83
Debt / EBITDA	1.86
Debt / FCF	2.95
Interest Coverage	5.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	24.48%
Revenue Per Employee	263,046
Profits Per Employee	29,602
Employee Count	7,836
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Diagnostyka has paid 60.65 million in taxes.

Income Tax	60.65M
Effective Tax Rate	20.12%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	170.26
200-Day Moving Average	n/a
Relative Strength Index (RSI)	84.60
Average Volume (20 Days)	63,274

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diagnostyka had revenue of PLN 2.06 billion and earned 231.96 million in profits. Earnings per share was 6.87.

Revenue	2.06B
Gross Profit	1.58B
Operating Income	332.37M
Pretax Income	301.41M
Net Income	231.96M
EBITDA	391.77M
EBIT	332.37M
Earnings Per Share (EPS)	6.87

Balance Sheet

The company has 33.56 million in cash and 933.21 million in debt, giving a net cash position of -899.65 million or -26.65 per share.

Cash & Cash Equivalents	33.56M
Total Debt	933.21M
Net Cash	-899.65M
Net Cash Per Share	-26.65
Equity (Book Value)	509.12M
Book Value Per Share	14.58
Working Capital	-68.83M

Cash Flow

In the last 12 months, operating cash flow was 445.18 million and capital expenditures -128.79 million, giving a free cash flow of 316.39 million.

Operating Cash Flow	445.18M
Capital Expenditures	-128.79M
Free Cash Flow	316.39M
FCF Per Share	9.37

Margins

Gross margin is 76.62%, with operating and profit margins of 16.12% and 11.25%.

Gross Margin	76.62%
Operating Margin	16.12%
Pretax Margin	14.62%
Profit Margin	11.25%
EBITDA Margin	19.01%
EBIT Margin	16.12%
FCF Margin	15.35%

Dividends & Yields

This stock pays an annual dividend of 3.31, which amounts to a dividend yield of 1.66%.

Dividend Per Share	3.31
Dividend Yield	1.66%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	45.55%
Buyback Yield	n/a
Shareholder Yield	1.69%
Earnings Yield	3.45%
FCF Yield	4.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Diagnostyka has an Altman Z-Score of 4.07 and a Piotroski F-Score of 3.

Altman Z-Score	4.07
Piotroski F-Score	3